Table 2 Statistics of the two platform datasets used in the present study.

   PC9

DMSO

1,938,496

1,683,528

44

gefitinib

1,728,426

1,502,134

22

   II-18

DMSO

1,071,312

904,648

47

gefitinib

1,169,322

985,941

47

   H1650

DMSO

1,158,863

1,018,527

47

gefitinib

1,283,908

1,126,651

47

   H1975

DMSO

846,215

725,523

47

gefitinib

866,011

744,728

47

   H2228

DMSO

1,362,097

1,183,384

47

gefitinib

1,269,704

1,092,511

47

   PC9 replicate

DMSO

1,362,097

1,183,384

47

Statistics of the micro-droplet system data used in the present study

Cell line

Treatment

Total raw reads

Total used reads

Number of Cells with >5 k tags

   PC9

DMSO

127,631,437

64,433,148

5,166

gefitinib

170,913,768

55,473,258

4,378

   II-18

DMSO

173,605,651

57,839,961

4,965

gefitinib

164,734,523

65,419,730

5,287

   H1650

DMSO

100,094,271

49,223,558

4,348

gefitinib

111,008,829

54,577,170

5,140

   H1975

DMSO

161,777,133

33,499,006

3,079

gefitinib

173,096,952

56,825,197

4,940

   H2228

DMSO

176,666,104

61,861,660

5,354

gefitinib

149,011,834

43,740,708

5,008

   H1975 replicate

DMSO

139,741,411

59,100,428

5,152